Sandman, L <br/><br/>
Risk factors for rifampin-monoresistant tuberculosis: A case-control study.  [electronic resource] 

 -  American journal of respiratory and critical care medicine  Feb 1999 
 - 468-72 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1073-449X 
<br/><br/><label>Standard No.: </label>10.1164/ajrccm.159.2.9805097  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS-Related Opportunistic Infections--diagnosis<br/>Adult<br/>Aged<br/>Antibiotics, Antitubercular--therapeutic use<br/>CD4 Lymphocyte Count<br/>Case-Control Studies<br/>Drug Resistance, Microbial<br/>Female<br/>Follow-Up Studies<br/>HIV--immunology<br/>HIV Seropositivity--diagnosis<br/>Humans<br/>Length of Stay<br/>Male<br/>Middle Aged<br/>Mycobacterium tuberculosis--drug effects<br/>Rifampin--therapeutic use<br/>Risk Factors<br/>Treatment Outcome<br/>Tuberculosis, Pulmonary--diagnosis